CA2974179C - Topical antibiotic formulations - Google Patents

Topical antibiotic formulations Download PDF

Info

Publication number
CA2974179C
CA2974179C CA2974179A CA2974179A CA2974179C CA 2974179 C CA2974179 C CA 2974179C CA 2974179 A CA2974179 A CA 2974179A CA 2974179 A CA2974179 A CA 2974179A CA 2974179 C CA2974179 C CA 2974179C
Authority
CA
Canada
Prior art keywords
formulation
silver
less
carboxylate
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2974179A
Other languages
English (en)
French (fr)
Other versions
CA2974179A1 (en
Inventor
Shalom Lampert
Perry Antelman
Bharat MADHAVAN
Joshua Steven STEIN
Elia ALTABET
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aidance Skincare and Topical Solutions LLC
Original Assignee
Aidance Skincare and Topical Solutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aidance Skincare and Topical Solutions LLC filed Critical Aidance Skincare and Topical Solutions LLC
Publication of CA2974179A1 publication Critical patent/CA2974179A1/en
Application granted granted Critical
Publication of CA2974179C publication Critical patent/CA2974179C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2974179A 2014-01-27 2015-01-27 Topical antibiotic formulations Active CA2974179C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461931944P 2014-01-27 2014-01-27
US61/931,944 2014-01-27
PCT/IB2015/050630 WO2015111032A1 (en) 2014-01-27 2015-01-27 Topical antibiotic formulations

Publications (2)

Publication Number Publication Date
CA2974179A1 CA2974179A1 (en) 2015-07-30
CA2974179C true CA2974179C (en) 2022-06-21

Family

ID=53680912

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2974179A Active CA2974179C (en) 2014-01-27 2015-01-27 Topical antibiotic formulations

Country Status (12)

Country Link
US (1) US9901541B2 (OSRAM)
EP (1) EP3099310B1 (OSRAM)
JP (1) JP6622218B2 (OSRAM)
KR (1) KR102292758B1 (OSRAM)
CN (1) CN106211756B (OSRAM)
AU (1) AU2015208739B2 (OSRAM)
CA (1) CA2974179C (OSRAM)
IL (1) IL246981B (OSRAM)
MX (1) MX383014B (OSRAM)
RU (1) RU2681544C2 (OSRAM)
WO (1) WO2015111032A1 (OSRAM)
ZA (1) ZA201605935B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10376541B2 (en) * 2014-01-27 2019-08-13 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
ES2979247T3 (es) * 2017-04-07 2024-09-25 Univ Western Australia Un método para ensayar la sensibilidad a los antimicrobianos

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728323A (en) * 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
JPH03141205A (ja) * 1989-10-24 1991-06-17 Ajinomoto Co Inc 抗菌剤
US20020127282A1 (en) * 1991-12-05 2002-09-12 N. Jonas & Co., Inc. A/K/A N. Jonas & Co. Multivalent silver pharmaceuticals
US5491059A (en) 1994-10-31 1996-02-13 Minnesota Mining And Manufacturing Company Silver carboxylate compounds as silver sources in photothermographic and thermographic elements
JPH0967231A (ja) * 1995-09-01 1997-03-11 Nikko Kemikaruzu Kk 脂肪酸銀を含有する抗菌剤組成物及び該脂肪酸銀を含有する化粧品
NZ512267A (en) * 1998-11-09 2003-11-28 Ira Jay Newman Ionic silver complex
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
JP4303915B2 (ja) * 2002-05-31 2009-07-29 山口 康子 抗菌性組成物及びその製造方法
US20050069502A1 (en) * 2003-08-15 2005-03-31 Chopra Suman K. Hydrophobic polymer carrier based liquid tooth whitening composition
EP1781098B1 (en) * 2004-07-30 2015-10-07 Avent, Inc. Antimicrobial devices and compositions
CN101336640A (zh) * 2008-08-29 2009-01-07 宜兴市乔阳电器有限公司 四氧化四银杀菌剂、制备方法及其应用
GB2472126B (en) * 2009-07-21 2011-08-03 Aidance Skincare & Topical Solutions Llc Topical Formulations Containing Silver (II) Oxide and Zinc Oxide
FI20115692A7 (fi) * 2011-06-30 2012-12-31 Silverphase Oy Polymeerinen antimikrobinen lisäaine

Also Published As

Publication number Publication date
US9901541B2 (en) 2018-02-27
JP2017503864A (ja) 2017-02-02
MX2016009696A (es) 2017-03-27
KR20160112004A (ko) 2016-09-27
CN106211756A (zh) 2016-12-07
KR102292758B1 (ko) 2021-08-24
MX383014B (es) 2025-03-12
WO2015111032A1 (en) 2015-07-30
AU2015208739A1 (en) 2016-08-25
ZA201605935B (en) 2017-11-29
RU2016134417A (ru) 2018-03-01
JP6622218B2 (ja) 2019-12-18
AU2015208739B2 (en) 2020-04-16
EP3099310A4 (en) 2017-07-26
EP3099310A1 (en) 2016-12-07
CN106211756B (zh) 2019-12-27
IL246981A0 (en) 2016-09-29
EP3099310B1 (en) 2025-10-01
CA2974179A1 (en) 2015-07-30
RU2681544C2 (ru) 2019-03-11
RU2016134417A3 (OSRAM) 2018-09-20
US20160184221A1 (en) 2016-06-30
IL246981B (en) 2021-02-28
EP3099310C0 (en) 2025-10-01

Similar Documents

Publication Publication Date Title
Rauf et al. Biomimetically synthesized ZnO nanoparticles attain potent antibacterial activity against less susceptible S. aureus skin infection in experimental animals
Javed et al. Effect of capping agents: structural, optical and biological properties of ZnO nanoparticles
Kim et al. Preparation and characterization of positively surface charged zinc oxide nanoparticles against bacterial pathogens
Al-Enizi et al. Cellulose gum and copper nanoparticles based hydrogel as antimicrobial agents against urinary tract infection (UTI) pathogens
Sana et al. Eco-friendly and facile production of antibacterial zinc oxide nanoparticles from Grewia flavescens (G. flavescens) leaf extract for biomedical applications
TWI616478B (zh) 包含銅鹽的經改質以礦物爲基底的塡料
Kumari et al. Development and characterization of active poly (3-hydroxybutyrate) based composites with grapeseed oil and MgO nanoparticles for shelf-life extension of white button mushrooms (Agaricus bisporus)
JP2018076522A (ja) 銀含有組成物
Punitha et al. Antifouling activities of β-cyclodextrin stabilized peg based silver nanocomposites
Nagaiah et al. In vitro evaluation of silver-zinc oxide-eugenol nanocomposite for enhanced antimicrobial and wound healing applications in diabetic conditions
US9901541B2 (en) Topical antibiotic formulations
Nazeri et al. Er2TiO5@ Ag nanocomposites: enhanced photocatalysis and bacteria inactivation, and cytotoxicity
US11013763B2 (en) Topical antibiotic formulations
Hou et al. Enhanced antibacterial photodynamic therapy with Qu/Ce6@ ZIF-8 nanoplatform for Staphylococcus aureus control in food preservation
Elabbasy et al. Synthesis and characterization of polystyrene with embedded WO3/Te2O4 nanoparticles and carbon nanotubes to utilize as antibacterial and wound healing biomaterial‏
Pica et al. Antimicrobial performances of some film forming materials based on silver nanoparticles
Ande et al. PEG-functionalized ZnO nanoparticles synthesized by Co-precipitation for improved antibacterial performance
Rakshit et al. Exploring Heliotropium indicum Leaf Extract Assisted Green Synthesis of CuO Nanoparticles for Tetracycline Degradation and Antimicrobial Activity
KJ Green synthesis of titanium dioxide nanoparticles using Thymus vulgaris leaf extract for biological applications
JP2018076528A (ja) 銀含有濃縮物
Pratap et al. Improved antimicrobial efficacy of copper-engineered zirconium oxide nanoparticles against some foodborne bacterial strains, synthesised via a facile hydrothermal method
AU2021103328A4 (en) Synthesis and pharmacological evaluation of ibuprofen entrapped silver nanoparticles using herbals
Wan et al. Se/Ti3C2 nanoparticles with antimicrobial and antioxidant properties: Rapid phototherapy of periodontitis by modulating GPX1 expression in macrophages under NIR
Khan et al. Biomimetically synthesized ZnO nanoparticles attain potentantibacterial activity against less susceptible S. aureus skin infection in experimental animals Mohd. Ahmar Rauf, Mohammad Owais1*, Ravikant Rajpoot2, Faraz Ahmad1
Alfawadı et al. Evaluation of the Effect of the Size of Ramalina fraxinea Based Ag NPs on the Antimicrobial Activity

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20191219

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD

Year of fee payment: 10

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241217

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241217

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241217

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251207

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251215